W.L. Gore & Assoc. begins the payback of the more than $857 million it owes stent graft rival C.R. Bard for patent infringement with a $36 million royalty check. W.L. Gore & Associates began paying out the $857.4 million it owes C.R. Bard (NYSE:BCR) for infringing a stent graft patent with a $35.7 million royalty check, according to court documents. Gore could still be on the hook for another $206.5 million, according to the documents.
Help employers find you! Check out all the jobs and post your resume.